search
new
immunobiolog
canin
viscer
leishmaniasi
cvl
intensifi
last
decad
howev
still
remain
elucid
mechan
innat
immun
respons
situ
immun
ai
aim
studi
investig
kinet
cell
migrat
skin
dog
distinct
antigen
compound
lbsap
vaccin
major
find
indic
saponin
adjuv
alon
combin
leishmania
braziliensi
antigen
induc
strong
local
acut
inflammatori
reaction
howev
reaction
progress
ulcer
lesion
overal
cell
profil
found
sap
lbsap
compos
neutrophil
lymphocyt
eosinophil
also
increas
product
ino
sap
lbsap
group
thu
conclud
dog
immun
lbsap
saponin
adjuv
elicit
potenti
innateimmun
activ
statu
compat
effect
control
resist
infect
leishmania
contribut
better
understand
innateimmun
event
induc
lbsap
vaccin
viscer
leishmaniasi
vl
diseas
caus
leishmania
leishmania
chagasi
syn
leishmania
leishmania
infantum
constitut
seriou
health
problem
variou
region
mediterranean
america
sinc
dog
import
domest
reservoir
l
l
chagasi
within
latin
america
europ
natur
histori
canin
viscer
leishmaniasi
cvl
studi
extens
respect
parasit
load
differ
tissu
immunopatholog
chang
relat
progress
clinic
form
whilst
data
proven
valuabl
develop
tool
employ
evalu
chemotherapi
vaccin
cvl
current
treatment
strategi
fail
achiev
consist
parasitolog
cure
diseas
owe
presenc
latent
infect
cell
respect
canin
vaccin
may
repres
practic
effect
method
reduc
incid
human
vl
could
also
provid
basi
develop
similar
vaccin
human
search
potenti
vaccin
cvl
variou
approach
involv
dog
model
employ
use
purifi
fraction
parasit
extract
eg
fucos
mannos
ligand
fml
antigen
parasit
cultur
excretedsecret
antigen
shown
particular
promis
addit
remark
result
obtain
follow
vaccin
dog
kill
parasit
vaccin
thu
demonstr
vaccin
prepar
antigen
extract
still
remain
reliabl
proposit
consider
cost
safeti
broad
spectrum
antigen
context
recent
demonstr
kill
leishmania
braziliensi
togeth
saponin
lbsap
vaccin
instituto
nacion
da
propriedad
intelectualpat
pi
februari
saponin
saliva
lutzomyia
longipalpi
lbsapsal
vaccin
gener
high
level
immunogen
dog
vaccin
anim
exhibit
increas
number
circul
tcell
bcell
l
chagasispecif
tcell
repres
key
resist
profil
cvl
moreov
anim
receiv
saponin
adjuv
present
minor
local
swell
major
advers
reaction
indic
dog
overal
toler
candid
vaccin
appear
adequ
howev
studi
still
requir
overcom
potenti
problem
area
search
addit
safeti
biomark
associ
use
saponin
vaccin
adjuv
basi
investig
kinet
inflammatori
reaction
express
induc
nitric
oxid
synthas
ino
occur
skin
dog
follow
inocul
differ
antigen
compound
consid
initi
time
inoculum
h
approach
present
herein
repres
import
tool
possibl
explor
cell
profil
identifi
addit
safeti
biomark
paramet
earli
event
dermi
dog
immun
lbsap
vaccin
separ
compon
detail
propos
studi
present
approv
ethic
committe
use
experiment
anim
universidad
feder
de
mina
gerai
belo
horizont
mg
brazil
anim
popul
consist
mongrel
dog
male
femal
month
old
born
rais
kennel
institut
biolog
scienc
universidad
feder
de
ouro
preto
ouro
preto
mg
brazil
dog
treat
anthelmint
vaccin
rabi
tecpar
curitiba
pr
brazil
canin
distemp
type
adenoviru
coronaviru
parainfluenza
parvoviru
leptospira
vanguard
htlp
pfizer
anim
health
new
york
ny
usa
two
day
prior
experi
dorsal
area
anim
shave
local
reaction
observ
studi
popul
divid
four
group
three
dog
per
group
sap
group
inocul
mg
saponin
sigma
chemic
co
st
loui
mo
usa
lb
group
inocul
g
l
braziliensi
promastigot
protein
lbsap
group
inocul
g
l
braziliensi
promastigot
protein
mg
saponin
control
group
inocul
equival
volum
steril
salin
solut
adjuv
antigen
dilut
steril
salin
solut
total
volum
l
follow
applic
gener
anaesthet
thiopentax
itapira
sp
brazil
mgkg
bodi
weight
antigen
compon
lbsap
vaccin
placebo
inocul
shave
dorsal
area
anim
via
intraderm
inject
skin
biopsi
inocul
area
perform
h
order
evalu
kinet
cell
migrat
alter
ie
nodul
ulcer
lesion
produc
differ
substanc
area
record
skin
fragment
fix
buffer
formalin
ph
embed
paraffin
cut
section
histochem
histopatholog
analys
endogen
peroxid
block
incub
skin
section
hydrogen
peroxid
h
methanol
min
section
dewax
heat
microwav
oven
w
min
retriev
antigen
cool
room
temperatur
wash
phosphat
buffer
salin
pb
section
block
normal
hors
serum
vector
laboratori
burlingam
ca
usa
reduc
nonspecif
antibodi
bind
incub
primari
antibodi
ino
dilut
cat
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
c
overnight
wash
pb
min
section
incub
secondari
antibodi
conjug
biotin
elit
abc
kit
vector
laboratori
min
c
wash
pb
incub
streptavidinperoxidas
complex
min
c
reaction
product
peroxidas
visual
incub
pb
contain
mg
diaminobenzidin
dab
l
h
final
section
stain
nuclei
harri
haematoxylin
solut
neg
control
slide
prepar
absenc
primari
antibodi
standard
histolog
examin
morphometr
analysi
leukocyt
differenti
count
section
stain
haematoxylin
eosin
kinet
cell
migrat
evalu
within
three
skin
layer
outer
dermi
inner
dermi
hypodermi
submit
stain
histolog
prepar
immunohistochem
analysi
ino
subsequ
examin
olympu
optic
co
tokyo
japanmodel
optic
microscop
intens
predomin
cell
inflammatori
infiltr
distribut
within
skin
layer
assess
togeth
distribut
inosposit
cell
intens
express
regist
semiquantit
ie
absent
discreet
moder
intens
quantit
morphometr
analysi
inflammatori
cell
present
skin
layer
perform
acquir
digit
imag
premark
area
found
associ
ino
express
imag
captur
magnif
use
leica
microcamera
leica
microsystemsswitzerland
ltd
heerbrugg
switzerland
leica
applic
suit
softwar
version
analys
aid
leica
qwin
softwar
twenti
random
imag
total
area
determin
suffici
repres
analysi
slide
order
identifi
type
cell
recruit
site
differ
inocul
site
inflammatori
cell
neutrophil
eosinophil
macrophag
lymphocyt
count
result
express
percentag
statist
analys
perform
aid
softwar
packag
prism
prism
softwar
irvin
ca
usa
normal
data
establish
use
kolmogorovsmirnoff
test
oneway
analysi
varianc
anova
tukey
post
hoc
test
use
investig
differ
group
respect
cellular
infiltr
dermal
hypoderm
layer
associ
leukocyt
ino
cell
infiltr
dermi
hypodermi
investig
use
pearson
rank
correl
case
differ
consid
signific
p
valu
visual
inspect
experiment
dog
reveal
none
develop
advers
reaction
inoculum
except
local
oedema
individu
within
sap
group
alter
observ
onward
h
follow
inocul
remain
whole
studi
period
evolv
ulcer
lesion
histopatholog
examin
show
within
sap
lbsap
group
anim
present
oedema
congest
haemorrhag
degener
muscl
fibr
inocul
area
togeth
sign
signific
focal
inflamm
alter
observ
particularli
earli
period
h
follow
inocul
fig
g
continu
late
period
h
fig
sap
lbsap
inoculum
induc
pronounc
inflammatori
reaction
dermi
hypodermi
studi
anim
posit
correl
ino
express
fig
upper
lower
right
panel
signific
increas
inflammatori
infiltr
observ
dermi
anim
sap
group
h
compar
control
anim
group
h
lb
group
anim
also
exhibit
signific
increas
inflammatori
infiltr
compar
group
fig
upper
left
panel
longitudin
evalu
result
show
differ
within
group
concern
inflammatori
infiltr
period
investig
posit
correl
p
total
number
cell
nuclei
mark
area
ino
express
could
establish
sap
group
fig
upper
right
panel
hypodermi
inflammatori
infiltr
increas
significantli
within
sap
lbsap
group
h
comparison
lb
group
fig
lower
left
panel
fig
import
emphasis
increas
observ
within
sap
lbsap
group
occur
similar
time
h
inflammatori
infiltr
within
sap
group
significantli
enhanc
compar
group
longitudin
analysi
reveal
sap
lbsap
group
inflammatori
infiltr
significantli
increas
within
period
h
comparison
level
h
inocul
posit
correl
p
total
number
cell
nuclei
mark
area
ino
express
hypodermi
anim
within
lbsap
group
fig
lower
right
panel
antigen
l
braziliensi
lb
group
antigen
l
braziliensi
plu
saponin
lbsap
group
signific
differ
p
valu
associ
sap
lb
group
indic
letter
b
c
respect
right
panel
correl
number
cell
nuclei
ino
activ
within
skin
layer
sap
lbsap
group
r
pearson
correl
coeffici
antiino
immunohistochem
reaction
observ
three
skin
layer
sap
group
well
epidermi
keratinocyt
annex
sebac
sudoripar
gland
reaction
vari
semiquantit
basi
moder
intens
keratinocyt
discreet
intens
dermi
absent
intens
hypodermi
similar
level
ino
express
also
observ
lb
group
within
lbsap
group
ino
express
intens
keratinocyt
dermi
whole
studi
period
whilst
hypodermi
express
vari
moder
intens
ino
express
also
observ
gland
fibroblast
endotheli
cell
studi
group
fig
quantit
basi
ino
express
increas
significantli
within
sap
lbsap
group
h
compar
level
determin
h
inocul
fig
moreov
area
ino
express
significantli
increas
within
lb
group
compar
group
h
inocul
whilst
h
sap
lbsap
group
present
significantli
larger
area
ino
express
lb
group
increas
intens
ino
also
observ
h
within
lbsap
group
h
within
sap
group
differ
statist
signific
comparison
lb
group
longitudin
evalu
cell
migrat
reveal
percentag
neutrophil
increas
significantli
within
sap
group
h
compar
h
inocul
fig
upper
left
panel
follow
signific
reduct
h
number
neutrophil
outer
dermi
anim
sap
group
significantli
increas
h
compar
level
determin
lb
lbsap
group
percentag
eosinophil
within
lbsap
group
fig
lower
left
panel
increas
significantli
h
compar
valu
record
earlier
time
h
although
differ
group
statist
signific
concern
macrophag
reduct
observ
within
sap
group
h
compar
h
former
valu
significantli
lower
group
fig
upper
middl
panel
lbsap
group
present
significantli
reduc
number
macrophag
h
compar
lb
group
posit
correl
p
ino
express
percentag
macrophag
outer
dermi
lb
group
fig
right
panel
contrast
number
lymphocyt
increas
significantli
outer
dermi
member
lbsap
group
h
compar
valu
determin
h
follow
inocul
increas
statist
differ
determin
lb
group
h
fig
middl
left
panel
addit
number
lymphocyt
within
sap
lbsap
group
increas
significantli
h
compar
lb
group
longitudin
analysi
show
number
neutrophil
macrophag
lymphocyt
present
inner
dermi
anim
within
group
vari
significantli
studi
period
contrast
signific
variat
inflammatori
cell
profil
record
group
anim
thu
number
neutrophil
increas
significantli
h
inocul
within
sap
group
compar
lb
group
fig
upper
left
panel
furthermor
number
macrophag
reduc
significantli
h
within
lbsap
group
compar
group
h
compar
lb
group
fig
upper
middl
panel
addit
percentag
macrophag
significantli
reduc
h
within
sap
group
compar
group
regard
eosinophil
signific
increas
within
sap
group
h
inocul
compar
level
h
fig
lower
left
panel
also
within
lbsap
group
h
inocul
compar
valu
h
inner
dermi
sap
anim
posit
correl
p
observ
percentag
eosinophil
total
number
cell
nuclei
fig
lower
right
panel
whilst
member
lbsap
group
neg
correl
p
percentag
macrophag
ino
express
fig
upper
right
panel
longitudin
analysi
show
percentag
neutrophil
hypodermi
significantli
reduc
within
lbsap
group
h
compar
level
h
inocul
fig
upper
left
panel
moreov
compar
group
number
neutrophil
within
sap
lbsap
group
significantli
increas
h
inocul
whilst
lb
group
neutrophil
number
significantli
increas
h
compar
group
addit
lb
group
exhibit
signific
reduct
number
neutrophil
h
compar
h
level
import
mention
salin
group
present
tendenc
increas
count
neutrophil
h
suggest
possibl
interfer
inoculum
neutrophil
migrat
h
may
caus
tissu
injuri
regard
macrophag
percentag
significantli
reduc
within
lb
sap
lbsap
group
h
inocul
compar
group
fig
upper
right
panel
diminish
number
macrophag
still
observ
within
sap
lbsap
h
compar
group
h
percentag
macrophag
within
sap
lbsap
decreas
compar
lb
group
number
eosinophil
increas
significantli
within
sap
group
h
compar
valu
determin
h
h
percentag
eosinophil
particularli
high
compar
record
time
fig
lower
left
panel
although
differ
group
concern
number
lymphocyt
signific
increas
observ
antigen
l
braziliensi
plu
saponin
lbsap
group
signific
differ
p
valu
associ
lb
group
indic
letter
c
respect
lower
panel
photomicrograph
show
immunohistochem
detect
ino
express
dermi
plate
hypodermi
plate
dog
record
h
immun
lbsap
plate
show
neg
control
reaction
slide
shown
magnif
bar
antiino
immunohistochem
reaction
observ
three
skin
layer
well
epidermi
keratinocyt
fibroblast
inflamm
cell
antigen
l
braziliensi
plu
saponin
lbsap
group
signific
differ
p
valu
associ
lb
lbsap
group
indic
letter
c
respect
right
panel
correl
percentag
macrophag
ino
activ
outer
dermi
dog
lb
group
r
pearson
correl
coeffici
within
sap
group
h
compar
h
fig
lower
right
panel
emerg
reemerg
charact
vl
result
failur
author
fulli
control
reservoir
vector
also
opportunist
infect
parasit
vulner
individu
particularli
affect
aid
moreov
escal
diseas
aggrav
develop
drugresist
strain
leishmania
numer
anticvl
vaccin
contain
divers
antigen
adjuv
test
brazil
shown
promis
result
continu
effort
develop
vaccin
cvl
effici
safe
conduct
studi
two
new
prepar
name
lbsap
lbsapsal
antigen
l
braziliensi
lb
antigen
l
braziliensi
plu
saponin
lbsap
signific
differ
p
valu
associ
lb
group
indic
letter
c
respect
result
obtain
far
reveal
vaccin
possess
strong
immunogen
capac
induc
high
level
antileishmania
igg
well
lymphocyt
particularli
circul
vitro
l
chagasispecif
cell
furthermor
demonstr
vaccin
induc
immun
respons
compat
control
etiolog
agent
cvl
ie
intens
prolif
activ
l
chagasispecif
lymphocyt
increas
product
vitro
stimul
solubl
l
chagasi
antigen
present
studi
inflammatori
process
induc
inocul
area
antigen
adjuv
present
lbsap
vaccin
evalu
initi
h
period
basi
immun
infecti
agent
requir
particip
innat
adapt
immun
respons
determin
kinet
cell
migrat
inocul
area
extrem
relev
sinc
number
type
cell
recruit
immedi
inocul
stimul
innateimmun
system
influenc
develop
acquir
immun
although
studi
tend
focu
cytokin
profil
inflammatori
reaction
knowledg
cell
profil
local
inflammatori
infiltr
provid
inform
concern
immun
respons
microenviron
inocul
local
oedema
observ
follow
inocul
sap
lbsap
suggest
acut
inflammatori
respons
saponin
adjuv
import
induc
specif
immun
reaction
howev
oedema
evolv
ulcer
lesion
thu
demonstr
saponin
isol
combin
l
braziliensi
antigen
safe
employ
adjuv
giunchetti
et
al
observ
similar
reaction
dog
vaccin
lbsap
demonstr
nodul
emerg
vaccin
disappear
later
stage
thu
indic
lbsap
vaccin
well
toler
despit
presenc
saponin
adjuv
follow
inocul
fml
antigen
vaccin
leishmun
dog
present
moder
advers
reaction
includ
pain
anorexia
local
puffi
spontan
disappear
second
immun
advers
event
follow
immun
defin
fever
local
reaction
intussuscept
inconsol
cri
seizur
hypoton
hyporespons
episod
allerg
reaction
rash
asthenia
paresthesia
myalgia
idiopath
thrombocytopenia
human
biomark
local
reaction
associ
safeti
format
indur
swell
inform
onset
durat
size
nodul
presenc
granuloma
subcategori
nodul
inject
site
present
persist
nodul
mani
month
postimmun
biomark
associ
local
reaction
firm
tender
pain
pruritu
present
studi
vaccin
associ
hyperthermia
pain
fever
lymphadenopathi
gener
advers
reaction
herein
histopatholog
alter
oedema
haemorrhag
congest
observ
chiefli
within
sap
lbsap
group
intens
symptom
may
well
depend
puriti
saponin
employ
context
moder
intens
inflammatori
reaction
oedema
last
day
report
sheep
follow
subcutan
inocul
mg
saponin
addit
observ
discreet
alter
skin
lb
anim
h
inocul
could
induc
inocul
togeth
increas
vascular
permeabl
import
emphasis
howev
alter
much
less
intens
absenc
saponin
adjuv
morphometr
analysi
reveal
saponin
play
import
role
transfer
cell
dermi
judg
number
cell
inflammatori
infiltr
h
follow
inocul
sap
find
reinforc
assumpt
saponin
modul
immun
respons
stimul
antibodi
product
nonspecif
reaction
inflamm
cell
traffic
number
cell
observ
hypodermi
sap
lbsap
anim
larger
dermi
probabl
virtu
extens
vascularis
former
layer
demonstr
present
studi
inflammatori
infiltr
increas
within
sap
lbsap
group
h
compar
lb
group
also
sap
group
h
compar
group
sinc
throughout
whole
experiment
period
greater
cell
recruit
within
sap
group
lbsap
group
initi
assumpt
regard
role
saponin
transfer
inflammatori
cell
inocul
area
strengthen
within
sap
lbsap
group
increas
number
neutrophil
lymphocyt
decreas
number
macrophag
observ
variou
time
studi
period
late
period
follow
inocul
increas
number
eosinophil
inner
dermi
hypodermi
sap
anim
inner
outer
dermi
lbsap
anim
base
result
possibl
hypothesis
neutrophil
function
front
line
immun
system
respond
immedi
upon
request
direct
migrat
cell
inocul
area
hour
afterward
appear
therefor
neutrophil
particip
effect
adapt
immun
respons
begin
process
assumpt
support
sever
studi
role
neutrophil
consid
accord
appelberg
neutrophil
act
phagocyt
also
determin
inflammatori
immun
respons
cooper
cell
amplif
respons
moreov
neutrophil
play
role
acquir
adapt
immun
sinc
antigenpres
cell
apc
activ
lymphocyt
context
neutrophil
shown
migrat
infect
site
macrophag
dendrit
cell
first
cell
interact
lymphocyt
moreov
togeth
saponin
neutrophil
stimul
activ
lymphocyt
henc
contribut
entir
immunogen
process
report
suggest
neutrophil
oper
indirect
manner
apc
also
instrument
recruit
cell
ie
lymphocyt
monocyt
macrophag
immatur
dendrit
cell
product
chemokin
increas
number
eosinophil
within
sap
lbsap
group
end
experiment
period
h
suggest
immun
lb
antigen
saponin
gener
mix
cell
mediat
immun
respons
base
find
possibl
hypothesis
eosinophil
togeth
neutrophil
particip
effect
innateimmun
respons
inocul
area
respect
macrophag
reduct
number
cell
possibl
due
intens
migrat
neutrophil
inocul
area
occur
acut
process
inhibit
antigen
compon
vaccin
inde
macrophag
known
play
import
role
immunogen
respons
induc
saponincontain
vaccin
increas
number
lymphocyt
observ
outer
dermi
sap
lbsap
anim
h
inocul
also
h
lbsap
group
demonstr
role
saponin
rapid
effect
recruit
cell
inocul
area
coparticip
cell
associ
adapt
respons
activ
innat
respons
recent
discuss
berg
forman
accord
author
migrat
lymphocyt
repres
addit
mechan
sinc
cell
produc
via
interact
cytokin
independ
tcell
receptormajor
histocompat
complex
tcrmhc
mechan
destroy
infect
cell
henc
control
multipl
infecti
agent
mediat
initi
stage
acquir
immun
respons
presenc
lymphocyt
also
import
sinc
cell
produc
activ
macrophag
thu
increas
microbicid
capabl
product
cytokin
take
part
adapt
respons
control
leishmania
infect
base
evid
possibl
infer
select
recruit
lymphocyt
particularli
tcell
contribut
protect
immun
respons
cvl
anoth
featur
demonstr
import
saponin
adjuv
prompt
immunogen
lb
antigen
fact
within
lb
group
recruit
inflammatori
cell
inocul
area
rather
weak
contribut
inflammatori
cell
creation
microenviron
suitabl
immun
reaction
leishmania
infect
also
investig
examin
activ
ino
inocul
area
known
ino
express
key
factor
immun
adapt
respons
extern
stimuli
virul
pathogen
particularli
import
control
leishmania
parasit
semiquantit
analysi
demonstr
ino
express
skin
layer
anim
group
includ
control
group
find
lead
us
believ
stimuli
capac
increas
ino
express
contribut
product
particip
broad
rang
process
rang
nonspecif
reaction
modul
immun
system
quantit
analysi
ino
express
show
h
inocul
area
express
enzym
enlarg
within
lb
group
observ
explain
presenc
higher
number
macrophag
cell
consid
import
produc
recruit
outer
dermi
period
respons
lb
inoculum
contrast
sap
lbsap
group
show
larger
area
ino
express
h
onward
comparison
group
increas
ino
express
group
may
explain
great
number
noproduc
cell
recruit
inocul
area
activ
would
contribut
erad
parasit
correl
number
nuclei
ino
express
dermi
hypodermi
anim
sap
lbsap
group
confirm
assumpt
import
emphasis
ino
express
mani
type
cell
macrophag
neutrophil
fibroblast
respons
divers
stimuli
includ
cytokin
lipopolysaccharid
inde
numer
report
demonstr
type
cytokin
induc
ino
express
whilst
type
cytokin
diminish
leishmanicid
activ
murin
model
human
regul
ino
express
present
studi
shown
outer
dermi
lb
anim
percentag
macrophag
posit
correl
area
ino
express
suggest
lb
inoculum
activ
noproduc
macrophag
addit
within
sap
group
posit
correl
number
cell
nuclei
eosinophil
present
inner
dermi
suggest
cell
contribut
innat
respons
induc
strong
adjuv
power
saponin
role
inflammatori
reaction
skin
complex
sinc
low
level
induc
dilat
blood
vessel
migrat
neutrophil
whilst
high
level
regul
product
cell
adhes
molecul
suppress
activ
inflammatori
cell
induc
apoptosi
henc
influenc
balanc
type
type
respons
high
level
observ
group
inocul
saponin
may
relat
high
level
type
cytokin
essenti
activ
effector
mechan
product
control
leishmania
parasit
result
present
paper
demonstr
lbsap
vaccin
isol
saponin
adjuv
abl
induc
intens
cell
migrat
skin
inocul
dog
thu
trigger
initi
immunogen
event
moreov
compon
vaccin
shown
safe
sinc
ulcer
lesion
observ
inocul
site
studi
period
select
recruit
neutrophil
skin
intens
ino
express
exhibit
anim
sap
lbsap
group
similar
reaction
observ
anim
resist
infect
leishmania
